11 results about "Fructus phyllanthi" patented technology

The invention relates to the technical field of functional product preparation, and provides a rhizoma polygonati and saussurea involucrata bone marrow peptide tablet as well as a preparation method and application thereof. The rhizoma polygonati and saussurea involucrata bone marrow peptide tablet is prepared from the following components: collagen peptide powder, L-isoleucine, a compound nutrient supplement, rhizoma polygonati, sorbitol, yak bone marrow peptide powder, fructus phyllanthi, fructus alpiniae oxyphyllae, mulberry powder, a saussurea involucrata culture and magnesium stearate. All the components of the rhizoma polygonati and saussurea involucrata bone marrow peptide tablet disclosed by the invention have a synergistic effect, so that the effects of conditioning sub-health, maintaining joints and assisting in treating diseases can be achieved.

The invention discloses a composition for reducing uric acid. The composition is prepared from the following raw materials in parts by weight: 10 to 30 parts of fructus phyllanthi, 15 to 20 parts of fructus gardeniae, 15 to 20 parts of radix astragali seu hedysari and 35 to 50 parts of herba cichorii. The invention also provides a preparation method of the composition for reducing uric acid. The composition prepared by the invention is simple in component, high in XOD and URAT1 dual inhibitory activity, antioxidant activity and antiglycemic activity, and high in bioavailability of active components.

The invention relates to the technical field of medicine processing, in particular to a composition with a skin brightening effect and application of an oral preparation of the composition in medicines. The functional component of the composition is prepared from the following raw materials in parts by weight: 25 to 60 parts of fructus crataegi, 4 to 12 parts of folium mori, 1 to 6 parts of fructus phyllanthi, 0.1 to 1.2 parts of flos chrysanthemi, 0.5 to 5 parts of radix puerariae, 3 to 12 parts of rhizoma dioscoreae, 1 to 8 parts of poria cocos, 0.1 to 1 part of radix ginseng, 0.05 to 0.9 part of colla corii asini, 0.1 to 1 part of mangosteen and 40 to 100 parts of collagen peptide. The oral pharmaceutical preparation prepared from the composition disclosed by the invention has the effect of brightening skin color, is safe and convenient, and has a wide market prospect.

The invention relates to a solid beverage for maintaining intestinal-brain axes as well as a preparation method and application of the solid beverage, and belongs to the technical field of food processing. The health-care tea powder consists of cold-extracted freeze-dried tea powder, theanine powder, fructus phyllanthi powder, PQQ powder or microencapsulated PQQ powder, targeted probiotic microcapsule powder, mogroside and galactooligosaccharide. During preparation, the cold-extracted freeze-dried tea powder, the microencapsulated PQQ powder and the purchased targeted probiotic microcapsule powder are respectively prepared and then are mixed with other raw materials. The innovation of the invention lies in that the intestine-brain axis is synergistically maintained through a four-dimensional mechanism of anti-inflammatory and anti-oxidation-neuromodulation-mitochondrial activation-flora intervention, and the activity of the components is guaranteed by adopting technologies of cold extraction freeze-drying, microencapsulation and the like. The system can inhibit enteropathogenic bacteria, repair intestinal barriers, protect nervous systems, improve cognitive functions and regulate intestinal flora, has high technical feasibility and market prospects, and makes remarkable progress compared with the prior art.

The invention provides a liver-protecting medicinal and edible traditional Chinese medicine composition, a medicinal and edible product, a preparation method and application, and particularly belongs to the technical field of medicinal and edible traditional Chinese medicines. The medicinal and edible traditional Chinese medicine composition is prepared from the following components in parts by weight: 1 to 3.5 parts of semen cassiae, 0.5 to 2.5 parts of semen hoveniae, 0.1 to 1.5 parts of fructus phyllanthi and 0.1 to 1.5 parts of spica prunellae. The traditional Chinese medicine composition has the effect of remarkably improving the fatty liver and the non-alcoholic steatohepatitis, and a strategy which is low in cost and free of toxic and side effects can be provided for preventing or treating the non-alcoholic steatohepatitis.

The invention is suitable for the technical field of olive processing, and provides a phyllanthus emblica extraction device and process for production, the phyllanthus emblica extraction device comprises a squeezing box, a crushing box and a net-shaped belt conveying mechanism, the crushing box is fixedly installed at the top of the squeezing box and used for crushing phyllanthus emblica, passing openings are formed in the two corresponding sides of the squeezing box, and the net-shaped belt conveying mechanism is used for conveying the phyllanthus emblica through the passing openings. The net-shaped belt conveying mechanism is installed on the squeezing box in a penetrating mode through the two passing openings and used for receiving materials crushed by the crushing box, conveying the materials and conducting solid-liquid separation. According to the fructus phyllanthi extraction device for production provided by the scheme, the net-shaped belt conveying mechanism of the device combines the functions of material conveying and solid-liquid separation, solid waste residues can be automatically discharged out of the squeezing box, manual intervention is not needed, dripping liquid is secondarily filtered through the net-shaped filtering box, the purity of an extracting solution is further improved, and the production efficiency is improved. The problem that traditional extraction equipment is poor in solid-liquid separation effect is solved.

The invention provides Wickerhamomyces anomalus and an application thereof. The Wickerhamomyces anomalus provided by the invention is preserved in the China Center for Type Culture Collection on December 5, 2024, and the preservation number of the Wickerhamomyces anomalus is CCTCC NO: M 20242728. The Wickerhamomyces anomalus provided by the invention is suitable for brewing fruit wine, especially fructus phyllanthi fruit wine.

The invention discloses a traditional Chinese medicine composition for treating hepatic fibrosis, a traditional Chinese medicine preparation and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 90 to 110 parts of meconopsis, 40 to 60 parts of concretio silicea bambusae, 90 to 110 parts of flos carthami, 90 to 110 parts of fructus chebulae, 40 to 60 parts of radix inulae, 30 to 50 parts of herba taxilli paste, 90 to 110 parts of fructus phyllanthi and 3 to 20 parts of stigma croci. The invention further discloses a traditional Chinese medicine preparation for treating hepatic fibrosis and a preparation method thereof. The traditional Chinese medicine preparation can effectively solve the problems of low application safety and high curative effect heterogeneity of western medicines aiming at hepatic fibrosis in the non-alcoholic fatty liver disease at present.

The novel use of a medicinal and edible composition based on a qi regulating, blood circulating and toxin removing method in terms of amelioration of alcoholic fatty liver disease and chemical liver injury, uric acid reduction, etc. The medicinal and edible composition is prepared from the following raw material medicines by parts by weight: 3-13 parts of ginseng, 5-15 parts of fructus phyllanthi, 5-15 parts of raw coix seed, 1-12 parts of fructus citri, 1-12 parts of exocarpium citri grandis and 10-25 parts of dandelion.

The invention discloses a composition for inflammation conditioning sub-health and a preparation method thereof, and belongs to the technical field of health care products. The composition is prepared from the following raw materials in parts by mass: 20 to 25 parts of herba taraxaci, 7 to 10.5 parts of flos lonicerae, 18 to 23 parts of fructus phyllanthi, 2 to 5 parts of semen brassicae junceae, 12 to 18.4 parts of chickpea peptide, 6 to 10 parts of radix acanthopanacis semticosi, 3.1 to 6 parts of semen raphani and 2 to 5.2 parts of fructus perillae. The composition provided by the invention can effectively reduce the levels of key inflammatory factors such as TNF-alpha and IL-1beta, and conditions the inflammation sub-health symptoms.

The invention discloses a salivation promoting powder buccal cigarette which is composed of the following components in percentage by weight: 30%-55% of microcrystalline cellulose, 5%-15% of a salivation promoting powder formula, 1%-10% of a humectant, 1%-20% of a flavoring agent, 0.5%-6% of an acid-base regulator, 1%-30% of nicotine salt and 35%-60% of water. The sum of the weight percentages of the microcrystalline cellulose, the salivation promoting powder formula and the humectant is not higher than 60%, and the weight percentage ratio of the salivation promoting powder formula to the nicotine salt is 1: (1.5-2.5). 10% of the body fluid generating powder is added, the effect is remarkable, various plant components (such as plums, dendrobium nobile, radix ophiopogonis and fructus phyllanthi) in the body fluid generating powder have a synergistic effect, salivary secretion is stimulated, and the body fluid generating feeling fed back by a user is improved by 60% or above; plum and liquorice effectively provide salivation promoting and sweet aftertaste taste; the formula of the salivation promoting powder is cooperated with the humectant, so that the moist feeling of buccal cigarettes is prolonged, and the oral dryness is reduced.